Sunday, February 26, 2017 9:11:56 PM
- outcome: stop (as it is) or cont. (as it is) or futility
- interim event / announcement (start of the process, was March 31, 2016 @ 1st) - mmm.dd (d1)
- interim announcement (was September 12, 2016 @ 1st) - mmm.dd (d2)
- Eff% - xx.xx%
Rules (if you have different proposal, please advise):
* weight:
- interim event - 30% (w1)
- interim announcement (DMC recommendation) - 30% (w2)
- Eff% - 40% (w3)
(if interim event date won't be available: 50-50%)
* difference:
- D1: ABS (real interim event - d1)
- D2: ABS (real interim announcement (DMC recommendation) - d2)
* D3: difference in percentage 2 digits, eg. 1.15% diff = 115 score (Eff% - d2)
* d1 x w1+ d2 x w2 +d3 x w3 = score
* lowest score will win
"Sub-rules" (if you have different proposal, please advise):
- no data = the highest score in the category + 10%
...............................................................................................................................................................................
isaeed: stop / Jan. 31. / May. 15. / 23.67%
ziploc_1: stop / Feb. 01. / May. 01. / 35.00%
mrmainstreet: cont. / Feb. 01. / Jul. 03. / na
CaptBeer: cont. / Feb. 02. / Jun. 19. / na
KChung: stop / Feb. 23. / Jun. 12. / 34.00%
zumantu: stop / Feb. 23. / Jun. 22. / 30.50%
centurycom: stop / Feb. 23. / Aug. 16. / 28.00%
marzan: stop / Feb. 24. / May. 24. / 53.00%
HDGabor: stop / Feb 24. (10-K CC) / Jun 12. / 36.00%
drrc1949: stop / Feb. 27. / Aug. 09. / 35.00%
FlyFishingStocks: stop / Feb. 28. / May. 30. / 47.00%
Biofalcon: cont. / Mar. 06.*** / Jul. 20. / 23.00%*
rafunrafun: cont. / Mar. 13. / Jul. 17. / 33.00%*
invest2992: stop / Mar. 14. / Jul. 10. / 33.33%
Biobillionair: stop / Mar. 14. / Aug. 14. / 45.00%
tasgrewaf: stop / Mar. 15. / Jun. 15. / 23.45%
irc203: stop / Mar. 17. / Jul. 25. / 27.00%
slowmover: stop / Mar. 20. / Jun. 28. / 22.50%
lbwagain: stop / Mar. 20. / Jul. 12. / 33.00%
VuBru: stop / Mar. 21. / Jun. 20. / 19.50%
Hspooner: stop / Mar. 24. / Jun. 23. / 31.00%
ibew 488: stop / Mar. 24. / Jul. 27. / 35.00%
bfost: stop / Mar. 27.*** / Jul. 26. / 26.00%
Mochachip: stop / Mar. 31. / Jul. 31. / na
oneragman: stop / Mar. 31. / Aug. 07. / 31.00%
hayward: stop / Apr. 03.*** / Aug. 01. / 33.00%
Pharmacydude: stop / Apr. 03. / Sep. 05. / 25.00%
Nukemtiltheyglow: stop / Apr. 04. / Jun. 23. / 25.00%
Whalatane: stop / Apr. 17.*** / Jul. 31.*** / 19.00%
rydad21: stop / Apr. 17. / Jul. 17. / 24.00%
Hondo1021: stop / Apr. 20. / Jun. 23. / 28.00%
annac: stop /Apr. 24.*** / Jul. 24. / 20,00%
heysfguy: stop / Apr. 24.*** / Jul. 24.*** / 22.00%
...............................................................................................................................................................................
submitted after deadline:
Albino2: stop / Feb. 06. / May. 31. / 39.00%
Pyrrhonian: cont. / Mar. 02. / Jun. 12. / 5.00% *
Mikenac: stop / Mar. 16. / Jul. 12. / 35.00%
chas1232123: stop / Mar. 31. / May. 22.*** / 38.00%
staccani: stop / Mar. 31. / Jul. 17.*** / 27.00%
epenephrine: stop / Apr. 17.*** / Jun. 27. / 42.00%
Biobillionair: stop / Mar. 31. / Aug. 15. / 35.00% **
...............................................................................................................................................................................
* in case of cont. RRR projection is interesting ...
** only BB was entitled to submit more than one guess due to ...
*** Sat / Sun was modified for the next weekday
...............................................................................................................................................................................
Best,
G
#STRONGERTOGETHER
Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Recent AMRN News
- Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe • GlobeNewswire Inc. • 09/09/2024 11:30:00 AM
- Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:30:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:05:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 11:05:26 AM
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 07/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:30:08 PM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR) • GlobeNewswire Inc. • 07/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM